-
Something wrong with this record ?
Importance of thiopurine S-Methyltransferase gene polymorphisms for prediction of azathioprine toxicity
M. Kolorz, L. Bartosova, J. Hosek, D. Dvorackova, A. Chylkova, V. Zboril, M. Batovsky, M. Bartos
Language English Country Sweden
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NR9342
MZ0
CEP Register
PubMed
20027160
Knihovny.cz E-resources
- MeSH
- Alleles MeSH
- Azathioprine adverse effects blood MeSH
- Adult MeSH
- Genetic Predisposition to Disease MeSH
- Genotype MeSH
- Polymorphism, Single Nucleotide MeSH
- Leukopenia chemically induced MeSH
- Humans MeSH
- Methyltransferases genetics MeSH
- Polymerase Chain Reaction MeSH
- Polymorphism, Genetic MeSH
- Sequence Analysis, DNA MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVES: Our study aims to find the relationship between metabolic enzyme thiopurine S-methyltransferase (TPMT) gene polymorphisms and clinical output of the therapy with azathioprine. We focused on patients who experienced leucopenia caused by high blood levels of active azathioprine metabolites. DESIGN: Our group consists of 87 patients who have been treated by azathioprine. 21 individuals experienced leucopenia during treatment with standard dose of azathioprine. We have used PCR-REA and "real-time" PCR methods for genotype detection G238C, G460G and A719G substitutions in TPMT gene. RESULTS: We have found statistical association between the presence of non-standard TPMT alleles and adverse event associated with azathioprine treatment - leucopenia (p=0.0033). CONCLUSION: Our results confirm that TPMT genotyping prior to the treatment with azathioprine could predict patients with genetic predisposition for serious leucopenia and seems to be a useful genetic marker for individualisation of the therapy.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025381
- 003
- CZ-PrNML
- 005
- 20140721131611.0
- 007
- ta
- 008
- 120816s2009 sw f 000 0#eng||
- 009
- AR
- 035 __
- $a (PubMed)20027160
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Kolorz, Michal. $7 _BN006015 $u Department of Human Pharmacology and Toxicology, University of Veterinary and Pharmaceutical Sciences Brno,, Czech Republic. michalkolorz@seznam.cz
- 245 10
- $a Importance of thiopurine S-Methyltransferase gene polymorphisms for prediction of azathioprine toxicity / $c M. Kolorz, L. Bartosova, J. Hosek, D. Dvorackova, A. Chylkova, V. Zboril, M. Batovsky, M. Bartos
- 520 9_
- $a OBJECTIVES: Our study aims to find the relationship between metabolic enzyme thiopurine S-methyltransferase (TPMT) gene polymorphisms and clinical output of the therapy with azathioprine. We focused on patients who experienced leucopenia caused by high blood levels of active azathioprine metabolites. DESIGN: Our group consists of 87 patients who have been treated by azathioprine. 21 individuals experienced leucopenia during treatment with standard dose of azathioprine. We have used PCR-REA and "real-time" PCR methods for genotype detection G238C, G460G and A719G substitutions in TPMT gene. RESULTS: We have found statistical association between the presence of non-standard TPMT alleles and adverse event associated with azathioprine treatment - leucopenia (p=0.0033). CONCLUSION: Our results confirm that TPMT genotyping prior to the treatment with azathioprine could predict patients with genetic predisposition for serious leucopenia and seems to be a useful genetic marker for individualisation of the therapy.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a azathioprin $x škodlivé účinky $x krev $7 D001379
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a leukopenie $x chemicky indukované $7 D007970
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methyltransferasy $x genetika $7 D008780
- 650 _2
- $a polymerázová řetězová reakce $7 D016133
- 650 _2
- $a polymorfismus genetický $7 D011110
- 650 _2
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a sekvenční analýza DNA $7 D017422
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bartošová, Ladislava $7 ola2006340376
- 700 1_
- $a Hošek, Jan $7 xx0106185
- 700 1#
- $a Dvořáčková, D. $7 _AN036503
- 700 1#
- $a Chýlková, Alicja. $7 _AN052201
- 700 1_
- $a Zbořil, Vladimír, $d 1955- $7 mzk2005278248
- 700 1_
- $a Bátovský, Marián, $d 1951- $7 jo2007286430
- 700 1_
- $a Bartoš, Milan, $d 1964- $7 xx0037128
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 30 Suppl 1(2009), s. 137-142
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20027160 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20140721131918 $b ABA008
- 999 __
- $a ok $b bmc $g 947423 $s 782727
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2009 $b 30 Suppl 1 $d 137-142 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- GRA __
- $a NR9342 $p MZ0
- LZP __
- $a Pubmed-20120816/10/02